Artelo Biosciences's total assets for Q1 2026 were $12.52M, an increase of 346.91% from the previous quarter. ARTL total liabilities were $5.85M for the fiscal quarter, a 43.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.